Cargando…

CD44 in Ovarian Cancer Progression and Therapy Resistance—A Critical Role for STAT3

Despite significant progress in cancer therapy over the last decades, ovarian cancer remains the most lethal gynecologic malignancy worldwide with the five-year overall survival rate less than 30% due to frequent disease recurrence and chemoresistance. CD44 is a non-kinase transmembrane receptor tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martincuks, Antons, Li, Pei-Chuan, Zhao, Qianqian, Zhang, Chunyan, Li, Yi-Jia, Yu, Hua, Rodriguez-Rodriguez, Lorna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7736609/ https://www.ncbi.nlm.nih.gov/pubmed/33335857 http://dx.doi.org/10.3389/fonc.2020.589601

Ejemplares similares

PARP Inhibition Activates STAT3 in Both Tumor and Immune Cells Underlying Therapy Resistance and Immunosuppression In Ovarian Cancer
por: Martincuks, Antons, et al.
Publicado: (2021)

Niraparib-induced STAT3 inhibition increases its antitumor effects
por: Zhao, Qianqian, et al.
Publicado: (2022)

Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancer
por: Girda, Eugenia, et al.
Publicado: (2022)

The Therapeutic Effects of DDP/CD44-shRNA Nanoliposomes in AMF on Ovarian Cancer
por: Guo, Ting, et al.
Publicado: (2022)

CD44 Glycosylation as a Therapeutic Target in Oncology
por: Liao, Chengcheng, et al.
Publicado: (2022)

STING agonism overcomes STAT3-mediated immunosuppression and adaptive resistance to PARP inhibition in ovarian cancer
por: Ding, Liya, et al.
Publicado: (2023)

Enrichment of CD44 in Exosomes From Breast Cancer Cells Treated With Doxorubicin Promotes Chemoresistance
por: Wang, Xiaohong, et al.
Publicado: (2020)

Editorial: The role of STAT3 signaling pathway in tumor progression
por: Chang, Nan-Shan, et al.
Publicado: (2023)

A Systematic Review to Clarify the Prognostic Values of CD44 and CD44(+)CD24(-) Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
por: Abdoli Shadbad, Mahdi, et al.
Publicado: (2021)

Correlation of CD44v6 expression with ovarian cancer progression and recurrence
por: Shi, Jun, et al.
Publicado: (2013)

CD44 In Sarcomas: A Comprehensive Review and Future Perspectives
por: Fernández-Tabanera, Enrique, et al.
Publicado: (2022)

CD44 expressed by myeloid cells promotes glioma invasion
por: Ivanova, Ekaterina L., et al.
Publicado: (2022)

Long Non-Coding RNA CD27-AS1-208 Facilitates Melanoma Progression by Activating STAT3 Pathway
por: Ma, Jingjing, et al.
Publicado: (2022)

Matrix Hyaluronan-CD44 Interaction Activates MicroRNA and LncRNA Signaling Associated With Chemoresistance, Invasion, and Tumor Progression
por: Bourguignon, Lilly Y. W.
Publicado: (2019)

Overexpression of Specific CD44 Isoforms Is Associated with Aggressive Cell Features in Acquired Endocrine Resistance
por: Bellerby, Rebecca, et al.
Publicado: (2016)

Acetylation and activation of STAT3 mediated by nuclear translocation of CD44
por: Lee, Jia-Lin, et al.
Publicado: (2009)

CD44 Expression Predicts Prognosis of Ovarian Cancer Patients Through Promoting Epithelial-Mesenchymal Transition (EMT) by Regulating Snail, ZEB1, and Caveolin-1
por: Zhou, Jiayi, et al.
Publicado: (2019)

The Prognostic and Clinical Value of CD44 in Colorectal Cancer: A Meta-Analysis
por: Wang, Zhenpeng, et al.
Publicado: (2019)

Retraction Note: Correlation of CD44v6 expression with ovarian cancer progression and recurrence
por: Shi, Jun, et al.
Publicado: (2020)

CD44V3, an Alternatively Spliced Form of CD44, Promotes Pancreatic Cancer Progression
por: Zhu, Hanzhang, et al.
Publicado: (2022)

Prognostic Value of CD44 and Its Isoforms in Advanced Cancer: A Systematic Meta-Analysis With Trial Sequential Analysis
por: Han, Susu, et al.
Publicado: (2019)

CD44 expression in curettage and postoperative specimens of endometrial cancer
por: Wojciechowski, Michał, et al.
Publicado: (2014)

TIMELESS Promotes Tumor Progression by Enhancing Macrophages Recruitment in Ovarian Cancer
por: Xing, Xin, et al.
Publicado: (2021)

Key Roles of Hyaluronan and Its CD44 Receptor in the Stemness and Survival of Cancer Stem Cells
por: Chanmee, Theerawut, et al.
Publicado: (2015)

SFPQ Promotes Lung Cancer Malignancy via Regulation of CD44 v6 Expression
por: Yang, Libang, et al.
Publicado: (2022)

Radiation-Induced Reprogramming of Pre-Senescent Mammary Epithelial Cells Enriches Putative CD44(+)/CD24(−/low) Stem Cell Phenotype
por: Gao, Xuefeng, et al.
Publicado: (2016)

High expression of RARG accelerates ovarian cancer progression by regulating cell proliferation
por: Xiu, Lin, et al.
Publicado: (2022)

Macrophage Polarization in the Development and Progression of Ovarian Cancers: An Overview
por: Cheng, Huiyan, et al.
Publicado: (2019)

Expression and Function of CD44 in Epithelial Ovarian Carcinoma
por: Sacks, Joelle D., et al.
Publicado: (2015)

Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells
por: Lin, Li, et al.
Publicado: (2013)

Bromodomain Inhibition Attenuates the Progression and Sensitizes the Chemosensitivity of Osteosarcoma by Repressing GP130/STAT3 Signaling
por: Jiang, Yafei, et al.
Publicado: (2021)

Correlation between CD44 and membrane fluidity—a study on biopsies of high-grade serous ovarian tumor: Correlation between CD44 and membrane fluidity
por: Shi, Jun, et al.
Publicado: (2022)

The Value of MRI Findings Combined With Texture Analysis in the Differential Diagnosis of Primary Ovarian Granulosa Cell Tumors and Ovarian Thecoma–Fibrothecoma
por: Li, Nai-yu, et al.
Publicado: (2021)

Research progress on the premature ovarian failure caused by cisplatin therapy
por: Li, Zelin, et al.
Publicado: (2023)

Transient TKI-resistant CD44+pBAD+ blasts undergo intrinsic homeostatic adaptation to promote the survival of acute myeloid leukemia in vitro
por: Xu, Yi, et al.
Publicado: (2023)

CD44 Expression Profile Varies According to Maturational Subtypes and Molecular Profiles of Pediatric T-Cell Lymphoblastic Leukemia
por: Marques, Luísa Vieira Codeço, et al.
Publicado: (2018)

CD44 promotes multi-drug resistance by protecting P-glycoprotein from FBXO21-mediated ubiquitination
por: Ravindranath, Abhilash K., et al.
Publicado: (2015)

Interplay Between Chemotherapy-Activated Cancer Associated Fibroblasts and Cancer Initiating Cells Expressing CD44v6 Promotes Colon Cancer Resistance
por: Ghatak, Shibnath, et al.
Publicado: (2022)

Deregulation of Lipid Metabolism: The Critical Factors in Ovarian Cancer
por: Ji, Zhaodong, et al.
Publicado: (2020)

STAT3 mediates resistance of CD44(+)CD24(−/low) breast cancer stem cells to tamoxifen in vitro
por: Wang, Xiaoyan, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vf73276tquu8k7ra17fk8dtgf8